A growing coalition of universities, health care providers, bioscience leaders, and startups—anchored by Washington University and BioSTL—is working to position St. Louis as a global leader in neuroscience research and innovation. At the center of the effort is NEURO360, an ambitious plan to expand cutting-edge research, create career pathways, and build a thriving ecosystem around brain health and neurological technology in St. Louis. But the project’s full vision hinges on a pivotal $160 million federal grant from the National Science Foundation. With the grant program now in jeopardy amid sweeping cuts under the Trump administration, the coalition faces mounting uncertainty.
Still, optimism remains strong. The group has already secured over $60 million in local resources and unveiled major investments, including WashU’s new $616 million Neuroscience Research Building. Leaders say the work will move forward with or without federal funding—though the scale may need to adjust. For those driving the Neuro360 vision, the goal is clear: to ensure St. Louis becomes a destination for world-class neuroscience.
Search
